In this study, we found that osimertinib‐resistant, EGFR‐mutant NSCLC cells could produce exosomes with abundant miR‐210‐3p promoting EMT and drug resistance in osimertinib‐sensitive cells. Here, EGFR is linked to non-small cell lung carcinoma.